Markets:

Overview

News

Currencies

International

Treasuries

Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

77.01 -1.28 (-1.63%)

Streaming Delayed Price Updated: 3:35 PM EST, Feb 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Establishment Labs to Present at Jefferies Global Healthcare Conference

June 03, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

May 14, 2025

Via Benzinga

Establishment Labs Reports First Quarter 2025 Financial Results

May 07, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Appoints Peter Caldini as Chief Executive Officer

May 07, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

Exploring Establishment Labs Hldgs's Earnings Expectations ↗

November 06, 2024

Via Benzinga

Critical Insights From Establishment Labs Hldgs Analyst Ratings: What You Need To Know ↗

October 01, 2024

Via Benzinga

Establishment Labs to Announce First Quarter 2025 Financial Results on May 7

April 24, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12

April 10, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025

March 20, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Deep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (5 Ratings) ↗

August 22, 2024

Via Benzinga

Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance

February 26, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs to Present at TD Cowen's 45th Annual Health Care Conference

February 25, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs to Present at Citi’s 2025 Unplugged Medtech and Life Sciences Access Day

February 21, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Launches Preservé™

February 18, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26

February 14, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Announces CEO Transition

January 13, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Announces Participation in Upcoming Investment Conferences

November 11, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Announces $50 Million Registered Direct Offering

November 07, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Reports Third Quarter 2024 Financial Results

November 07, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants

October 31, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7

October 24, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Publishes 2024 Post Market Surveillance Report

October 15, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants

October 02, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 27, 2024

Via Benzinga

Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗

September 27, 2024

Via Benzinga

Establishment Labs Receives U.S. FDA Approval for Motiva Implants

September 26, 2024

From Establishment Labs Holdings Inc.

Via Business Wire

ESTA Stock Earnings: Establishment Labs Hldgs Misses EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

ESTA stock results show that Establishment Labs Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.